CDER soliciting comments regarding clinical trial innovation

F

FDA

Guest
Today, CDER announced that the center is soliciting public comments to understand the state of innovation in clinical trial design and conduct. CDER is gathering information from internal and external stakeholders on the barriers and facilitators to incorporating innovative clinical trial approache


Baca selengkapnya di : http://www.fda.gov...
 
Top